Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
You are here
Home
News by month %2 2012
News by month July 2012
PTCommunity News July 2012
Rituxan Effective in Refractory Rheumatoid Arthritis
Diagnostic Test for Ovarian Cancer Achieves Positive Results
“Whistle-Blower” at Center of FDA Spying Scandal
New Influenza Virus Highlights Risk of Pandemic Flu From Animals
Etanercept Deemed Safe for Treatment of Psoriasis
FDA Rejects Methylnaltrexone Bromide for Opioid-Induced Constipation
Drug Distributor McKesson Pays $151 Million Settlement for Medicaid Fraud
Company Launches Generic Sporanox Capsules
Bone Marrow Transplant Eliminates Signs of HIV Infection
FDA Approves Icosapent Ethyl for Triglyceride Reduction in Adults
FDA Approves Rayos for Rheumatoid Arthritis and Other Diseases
Health Experts Call for New Painkiller Labels to Stop Abuse
IDX719 Receives Fast Track Designation for Treatment of Chronic Hepatitis C Infection
FDA Says Ranibizumab May Help Diabetic Eye Condition
Survey Probes Employers’ Opinions About Affordable Care Act
NIH to Test Dapivirine Vaginal Ring for HIV Prevention in Women
FDA Grants Priority Review for Promacta for Treatment of Thrombocytopenia in Adults With Chronic HCV
FDA Rebuffs Injectafer for Iron Deficiency Anemia
FDA Warns About Seizure Risk With MS Drug Ampyra
Gabapentin Reduces Pain of Postherpetic Neuralgia in Phase 3 Trial
Experts Criticize Lipid Screening Guidelines for Children
FDA Clears Aclidinium Bromide for COPD
Results Announced From Phase 3 Trial of Erlotinib and Sorafenib Combination for Liver Cancer
FDA Approves Afinitor for Advanced Breast Cancer
FDA Approves Kyprolis for Multiple Myeloma
Lack of Insurance Linked to Advanced-Stage Cervical Cancer
AAOS Warns That Reduction in Number of Solo Practices Could Negatively Affect Patients and Economy
BPS Cites Increased Demand for Board-Certified Pharmacists
Celladon Receives Patent for Heart Failure Drug
Gene Therapy Nears Regulatory Approval in Europe
LDL Cholestrol-Lowering Antibody Enters Phase 3 Trials
Bristol-Myers Squibb Drug Fails Liver Cancer Trial
Study Shows Colon and Rectal Tumors Are Same Type of Cancer
Phase 3 Trial Evaluates Rebamipide Ophthalmic Suspension in Patients With Dry Eye Syndrome
New AAN Guideline on Treatment of Chorea in Huntington’s Disease
AMCP Offers Model Audit Guidelines for Pharmacy Claims
GSK Initiates Phase 3 Study of Herpes Zoster Vaccine
Biomarker in Blood May Help Predict Alzheimer’s Disease
Cancer Specialists Support PSA Testing for Men With Longer Life Expectancies
NIH Tools Help Researchers Match Cancer Drugs With Gene Targets
Preliminary Results Reported From Phase III Study of Feraheme in Patients With Iron Deficiency Anemia
FDA Approves Weight-Loss Drug Qsymia
Focus on Risk Factors for Stroke and Dementia Saved Lives, Money
Global EUCLID Trial Will Compare Ticagrelor and Clopidogrel in Patients With Peripheral Arterial Disease
Janssen Requests Approval of Golimumab for Treatment of Ulcerative Colitis
FDA Approves Truvada for Reducing Risk of Acquiring HIV
Cancer Drugs Recalled for Embedded Glass Particles in Vials
AHA/ACCF Issue Updated Guidelines for Unstable Angina
Neupro Launched in U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
AIDS Vaccine May Be Within Reach
New Fluticasone Furoate/Vilanterol Combo Drug Submitted for FDA Review
FDA Approves Generic Labetalol for Hypertension
Phase 3 Results for Kogenate FS Presented at Hemophilia Meeting
Pivotal Phase 3 Studies Planned for Treatment of <i>Clostridium Difficile</i>-Associated Diarrhea
Academic, AstraZeneca Scientists Join to Study Key Risk Factor for Alzheimer’s Disease
Scientists Discover Multiple Sclerosis-Specific Antibody
New Guidance for Pediatric Electronic Health Records Available From NIST
Apremilast, Experimental Psoriatic Arthritis Drug, Shows Promising Results in Phase 3 Trial
Phase 3 Trial of Odanacatib for Osteoporosis Is Halted Early After Drug Meets Efficacy Endpoints
Researchers Identify Key Proteins Involved in Neurodegeneration of Huntington’s Disease
Moderate Alcohol Consumption May Help Prevent Bone Loss in Postmenopausal Women
FDA Unveils Safety Measures for Opioid Painkillers
More People Can Receive Smallpox Vaccine in an Emergency
Using Interactive Preventive Health Record Enhances Delivery of Recommended Care
Swine Flu Vaccine Linked to Increased Risk of Guillain-Barré Syndrome
FDA Stops Phase 3 Trials of IB1001, Recombinant Factor IX Therapy for Hemophilia B
Preliminary Results Announced From Phase 3 Study of Halaven (Eribulin Mesylate) in Breast Cancer
FDA Grants Priority Review for New Uses of Anticlotting Drug Xarelto
Researchers Discover Cell-Signaling Molecule in Immune System That May Help Treat Skin Cancer
FDA Approves Combination of Erbitux (Cetuximab) and FOLFIRI Regimen as First-Line Treatment for Metastatic Colorectal Cancer
Silk-based Stabilizer Keeps Vaccines, Antibiotics Viable Without Refrigeration
Generic Version of Boniva Launched in United States
Similar Blood Glucose Improvements Seen With Linagliptin and Glimeperide
Positive Phase III Results Reported for Once-Daily LAMA/LABA in COPD
GSK Settles Fraud Case for $3 Billion
Development for Zertane-ED, Combo Drug for Premature Ejaculation and Erectile Dysfunction, Continues
Single I.V. Dose of Ondansetron May Affect Heart's QT Interval
FDA Panel Sees Little Use for Metal-on-Metal Hips
